High-throughput genotyping of Plasmodium vivax in the Peruvian Amazon via molecular inversion probes

Nat Commun. 2024 Nov 25;15(1):10219. doi: 10.1038/s41467-024-54731-y.

Abstract

Plasmodium vivax transmission occurs throughout the tropics and is an emerging threat in areas of Plasmodium falciparum decline, causing relapse infections that complicate treatment and control. Targeted sequencing for P. falciparum has been widely deployed to detect population structure and the geographic spread of antimalarial and diagnostic resistance. However, there are fewer such tools for P. vivax. Leveraging global variation data, we designed four molecular inversion probe (MIP) genotyping panels targeting geographically differentiating SNPs, neutral SNPs, putative antimalarial resistance genes, and vaccine candidate genes. We deployed these MIP panels on 866 infections from the Peruvian Amazon and identified transmission networks with clonality (IBD[identity by descent]>0.99), copy number variation in Pvdbp and multiple Pvrbps, mutations in antimalarial resistance orthologs, and balancing selection in 13 vaccine candidate genes. Our MIP panels are the broadest genotyping panel currently available and are poised for successful deployment in other regions of P. vivax transmission.

MeSH terms

  • Antimalarials / pharmacology
  • Antimalarials / therapeutic use
  • DNA Copy Number Variations
  • Drug Resistance / genetics
  • Genotype
  • Genotyping Techniques* / methods
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Malaria, Vivax* / epidemiology
  • Malaria, Vivax* / parasitology
  • Malaria, Vivax* / transmission
  • Molecular Probes
  • Peru / epidemiology
  • Plasmodium vivax* / genetics
  • Polymorphism, Single Nucleotide*
  • Protozoan Proteins / genetics

Substances

  • Antimalarials
  • Molecular Probes
  • Protozoan Proteins